Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fesoterodine with tolterodine evaluated efficacy and safety in overactive bladder. Results were posted following completion in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Detrol (tolterodine)
• Toviaz (fesoterodine fumarate)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2009-09-03